The C-terminal domain of Clostridium perfringens alpha toxin as a vaccine candidate against bovine necrohemorrhagic enteritis.

Abstract

Bovine necrohemorrhagic enteritis is caused by Clostridium perfringens and leads to sudden death. Alpha toxin, together with perfringolysin O, has been identified as the principal toxin involved in the pathogenesis. We assessed the potential of alpha toxin as a vaccine antigen. Using an intestinal loop model in calves, we investigated the protection afforded by antisera raised against native alpha toxin or its non-toxic C-terminal fragment against C. perfringens-induced intestinal necrosis. Immunization of calves with either of the vaccine preparations induced a strong antibody response. The resulting antisera were able to neutralize the alpha toxin activity and the C. perfringens-induced endothelial cytotoxicity in vitro. The antisera raised against the native toxin had a stronger neutralizing activity than those against the C-terminal fragment. However, antibodies against alpha toxin alone were not sufficient to completely neutralize the C. perfringens-induced necrosis in the intestinal loop model. The development of a multivalent vaccine combining the C-terminal fragment of alpha toxin with other C. perfringens virulence factors might be necessary for complete protection against bovine necrohemorrhagic enteritis.

• Authors: Evy Goossens, Stefanie Verherstraeten, Bonnie R Valgaeren, Bart Pardon, Leen Timbermont, Stijn Schauvliege, Diego Rodrigo-Mocholí, Freddy Haesebrouck, Richard Ducatelle, Piet R Deprez, Filip Van Immerseel
• Journal: Veterinary research (Vet Res) Vol. 47 Issue 1 Pg. 52 (04 27 2016) ISSN: 1297-9716 [Electronic] England
• PMID: 27121298 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Bacterial Toxins
• Bacterial Vaccines
• Calcium-Binding Proteins
• Recombinant Proteins
• Type C Phospholipases
• alpha toxin, Clostridium perfringens

Topics

• Animals
• Animals, Newborn
• Antibody Formation (immunology)
• Bacterial Toxins (immunology, therapeutic use)
• Bacterial Vaccines (immunology, therapeutic use)
• Calcium-Binding Proteins (immunology, therapeutic use)
• Cattle
• Cattle Diseases (microbiology, prevention & control)
• Clostridium Infections (prevention & control, veterinary)
• Clostridium perfringens
• Enteritis (microbiology, prevention & control, veterinary)
• Enzyme-Linked Immunosorbent Assay (veterinary)
• Intestines (pathology)
• Male
• Necrosis
• Recombinant Proteins
• Type C Phospholipases (immunology, therapeutic use)